Figure 1.

Schematic representation of adipose‐derived stem cells (ADSCs) for regenerative therapies. ADSCs serve as an ideal candidate for regenerative medicine owing to their ability to differentiate into multilineages, facilitate angiogenesis, suppress apoptosis, and participate in immunoregulation. Numerous preclinical studies and clinical trials have demonstrated the therapeutic potential of ADSCs in fat grafting, wound healing, bone regeneration, skeletal muscle repair, tendon reconstruction, cartilage regeneration, cardiac repair, and nerve regeneration.